About us
- >
- About us >
- Information >
- Announcement
2023-07-25
Our invention patent for "Compound Activating AMPK and its Use" for the treatment of prediabetes and type 2 diabetes has been approved in Ca
Our patent application for "Compound for Activating AMPK and Uses Thereof" has been approved by Innovation, Science, and Economic Development Canada (ISED). The patent application number is 3112108. This approval signifies that the compound and its applications for activating AMPK have met the necessary requirements and have been granted patent protection in Canada.